The heavy chain, 4F2hc/CD98HC, is the product of the SLC3A2 gene, and following its glycosylation, it acts as a cofactor to direct its various light chain partners (SLC7A5-11,13
Two follow-up clinical trials also supported the use of Symbravo in treating migraines: MOVEMENT and EMERGE
Key effects include: Delivers bioavailable copper to activate critical copper-dependent enzymes Stimulates collagen, elastin, and glycosaminoglycan production, helping skin, tendons, and connective tissues regenerate Accelerates wound healing and supports remodeling of old or fibrotic tissue Regulates matrix metalloproteinases (MMPs) to balance tissue breakdown and rebuilding Reduces inflammation by lowering cytokines such as TNF-, IL-6, and TGF- Provides antioxidant protection by boosting copper-dependent enzymes Supports hair follicle health and dermal papilla cell activity Influences gene expression related to repair, regeneration, and cell protection Improves tissue resilience in skin, muscle, and joint structures May support cognitive and neural protection through antioxidant and anti-inflammatory mechanisms Key Research Areas and Potential Benefits 1
doi:10.1007/s10552-020-01280-6
10.3390/nu13072327 10 AsbaghiO.Ashtary-LarkyD.BagheriR.MoosavianS